Vartak A

References (2)

Title : The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse - Nickell_2014_Adv.Pharmacol_69_71
Author(s) : Nickell JR , Siripurapu KB , Vartak A , Crooks PA , Dwoskin LP
Ref : Advances in Pharmacology , 69 :71 , 2014
Abstract : Nickell_2014_Adv.Pharmacol_69_71
ESTHER : Nickell_2014_Adv.Pharmacol_69_71
PubMedSearch : Nickell_2014_Adv.Pharmacol_69_71
PubMedID: 24484975

Title : The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats - Beckmann_2010_J.Pharmacol.Exp.Ther_335_841
Author(s) : Beckmann JS , Siripurapu KB , Nickell JR , Horton DB , Denehy ED , Vartak A , Crooks PA , Dwoskin LP , Bardo MT
Ref : Journal of Pharmacology & Experimental Therapeutics , 335 :841 , 2010
Abstract : Beckmann_2010_J.Pharmacol.Exp.Ther_335_841
ESTHER : Beckmann_2010_J.Pharmacol.Exp.Ther_335_841
PubMedSearch : Beckmann_2010_J.Pharmacol.Exp.Ther_335_841
PubMedID: 20805303